EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 85 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $37 | -38.3% | 11,500 | -33.1% | 0.00% | – |
Q4 2022 | $60 | -100.0% | 17,200 | -22.2% | 0.00% | – |
Q4 2021 | $281,000 | +140.2% | 22,100 | +63.4% | 0.00% | – |
Q2 2021 | $117,000 | -54.7% | 13,521 | -49.2% | 0.00% | – |
Q1 2021 | $258,000 | +230.8% | 26,629 | +101.7% | 0.00% | – |
Q4 2020 | $78,000 | – | 13,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
Atom Investors LP | 40,855 | $496,000 | 0.23% |